Hostname: page-component-cb9f654ff-r5d9c Total loading time: 0 Render date: 2025-08-21T12:27:07.618Z Has data issue: false hasContentIssue false

A systematic review of SARS-CoV-2 associated sudden onset sensorineural hearing loss

Published online by Cambridge University Press:  04 April 2025

Maisie Fouweather*
Affiliation:
Department of Otolaryngology, Freeman Hospital, Newcastle Upon Tyne, UK Newcastle University Medical School, Newcastle University, Newcastle Upon Tyne, UK
Benjamin Talks
Affiliation:
Department of Otolaryngology, Freeman Hospital, Newcastle Upon Tyne, UK Newcastle University Medical School, Newcastle University, Newcastle Upon Tyne, UK
Nicholas Dawe
Affiliation:
Department of Otolaryngology, Freeman Hospital, Newcastle Upon Tyne, UK
Michael Mather
Affiliation:
Department of Otolaryngology, Freeman Hospital, Newcastle Upon Tyne, UK Newcastle University Medical School, Newcastle University, Newcastle Upon Tyne, UK
*
Corresponding author: Maisie Fouweather; Email: maisie.fouweather1@nhs.net

Abstract

Objectives

Sudden onset sensorineural hearing loss has been associated with infection by severe acute respiratory syndrome coronavirus-2. However, little is known regarding how this differs from sudden onset sensorineural hearing loss of other aetiologies. This systematic review summarises existing literature on severe acute respiratory syndrome coronavirus-2 associated sudden onset sensorineural hearing loss treatment and outcomes.

Methods

A literature search using Ovid was performed for studies which evaluated treatments and outcomes of patients with sudden onset sensorineural hearing loss associated with severe acute respiratory syndrome coronavirus-2 infection.

Results

A total of 99 studies were identified, from which 14 studies were selected for inclusion - collectively including 154 patients. Nine of these studies were single participant case reports and five were larger case series. Corticosteroid treatment varied between studies in terms of administration route, dose, and duration. Only 63/154 patients in this review achieved complete resolution of their symptoms following steroid treatment.

Conclusion

Oral, intravenous, and intratympanic steroids demonstrate a good safety profile. However, the majority of patients are left with unresolved hearing loss.

Information

Type
Main Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Maisie Fouweather takes responsibility for the integrity of the content of the paper

References

Alexander, TH, Harris, JP. Incidence of sudden sensorineural hearing loss. Otol Neurotol 2013;34:1586–9.CrossRefGoogle ScholarPubMed
Chandrasekhar, SS, Tsai, Do BS, Schwartz, SR, Bontempo, LJ, Faucett, EA, Finestone, SA, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg 2019;161:S145.Google Scholar
Schreiber, BE, Agrup, C, Haskard, DO, Luxon, LM. Sudden sensorineural hearing loss. Lancet 2010;375:1203–11CrossRefGoogle ScholarPubMed
Conway, EM, Mackman, N, Warren, RQ, Wolberg, AS, Mosnier, LO, Campbell, RA, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022;22:634–49.CrossRefGoogle ScholarPubMed
Awad, Z, Huins, C, Pothier, DD. Antivirals for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 20122012:CD006987Google Scholar
Horby, P, Lim, WS, Emberson, JR, Mafham, M, Bell, JL, Linsell, L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693704Google ScholarPubMed
Gagnier, JJ, Kienle, G, Altman, DG, Moher, D, Sox, H, Riley, D. The CARE guidelines: consensus based clinical case reporting guideline. Headache 2013;53:1541–7CrossRefGoogle ScholarPubMed
Page, MJ, McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffman, TC, Mulrow, CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71CrossRefGoogle ScholarPubMed
Lang, B, Hintze, J, Conlon, B. Coronavirus disease 2019 and sudden sensorineural hearing loss. J Laryngol Otol 2020;Oct 1:13Google Scholar
Rahimi, V, Rouhbakhsh, N, Asiyabar, MK. Sudden hearing loss and coronavirus disease 2019: The role of corticosteroid intra-tympanic injection in hearing improvement. J Laryngol Otol 2021;135:464–6CrossRefGoogle ScholarPubMed
Koumpa, FS, Forde, CT, Manjaly, JG. Sudden irreversible hearing loss post COVID-19. BMJ Cahse Rep 2020;13:e238419CrossRefGoogle ScholarPubMed
Lamounier, P, Gonçalves, VF, Ramos, HVL, Gobbo, DA, Costa, CC, Teixeira, RP, et al. A 67-year-old woman with sudden hearing loss associated with SARS-CoV-2 infection. Am J Case Rep 2020;21:e927519CrossRefGoogle ScholarPubMed
Edwards, M, Muzaffar, J, Naik, P, Coulson, C. Catastrophic bilateral sudden sensorineural hearing loss following COVID-19. BMJ Case Rep 2021;14:e243157CrossRefGoogle ScholarPubMed
Yaseen, NK, Al-Ani, RM, Ali Rashid, R. COVID-19-related sudden sensorineural hearing loss. Qatar Med J 2021;2021:58CrossRefGoogle ScholarPubMed
Pokharel, S, Tamang, S, Pokharel, S, Mahaseth, RK. Sudden sensorineural hearing loss in a post-COVID-19 patient. Clin Case Rep 2021;9:e04956CrossRefGoogle Scholar
Akbar, S, Gopikrishna, D, Leong, WJ. Unilateral, permanent hearing loss following severe COVID-19 infection. BMJ Case Rep 2022;15:e251717CrossRefGoogle ScholarPubMed
Essawy, WM. Effectiveness of oral corticosteroids (prednisolone) in sensorineural hearing loss post COVID-19. Egypt J Otolaryngol 2022;38:162CrossRefGoogle Scholar
Beckers, E, Chouvel, P, Cassetto, V, Mustin, V. Sudden sensorineural hearing loss in COVID-19: a case report and literature review. Clin Case Rep 2021;9:2300–4CrossRefGoogle ScholarPubMed
Tsuda, T, Hanada, Y, Wada, K, Fujiwara, E, Takeda, K, Nishimura, H. Efficacy of intratympanic glucocorticoid steroid administration therapy as an initial treatment for idiopathic sudden sensorineural hearing loss during the COVID-19 pandemic. Ear Nose Throat J 2021;102:772–9CrossRefGoogle Scholar
Rhman, SA, Wahid, AA. COVID-19 and sudden sensorineural hearing loss, a case report. Otolaryngol Case Rep 2020;16:100198CrossRefGoogle ScholarPubMed
Swain, SK, Das, S, Lenka, S. Sudden sensorineural hearing loss among COVID-19 patients-our experiences at an Indian teaching hospital. Siriraj Med J 2021;73:7783CrossRefGoogle Scholar
Peron, KA, Scott, MCP, Soeiro, TLT, JBd, Amaral, Chandrasekhar, SS, Penido Nd, O. Sudden sensorineural hearing loss: audiological profile during the COVID-19 pandemic. Front Neurol 2024;15:1415068CrossRefGoogle ScholarPubMed
Zhao, D, Tong, B, Wang, Q, Hellstrom, S, Duan, M. A comparison of effects of systemic and intratympanic steroid therapies for sudden sensorineural hearing loss: a meta-analysis. J Otol 2016;11:823.Google ScholarPubMed
Plontke, SK, Meisner, C, Agrawal, S, Cayé-Thomasen, P, Galbraith, K, Mikulec, AA, et al. Intratympanic corticosteroids for sudden sensorineural hearing loss. Cochrane Database Syst Rev 2022;7:CD008080Google ScholarPubMed
National Institute for Health and Care Excellence. Hearing loss in adults: assessment and management. 2018. In: https://pubmed.ncbi.nlm.nih.gov/30011159/ [8 May 2025]Google Scholar
Mattox, DE, Simmons, FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–80CrossRefGoogle ScholarPubMed
Mohammed, H, Ahmad, N, Banerjee, A. Prevalence and management of sudden sensorineural hearing loss during the COVID-19 crisis: how do we do it and our experience in twelve patients. Authorea. In: https://www.authorea.com/users/326121/articles/474995-prevalence-and-management-of-sudden-sensorineural-hearing-loss-during-the-covid-19-crisis-how-do-we-do-it-and-our-experience-in-twelve-patients?commit=2a6f06088dd0284783ec013af020e022a96b5ea2 [8 May 2025]Google Scholar
Smith, ME, Knappett, R, Vickers, D, White, D, Schramm, CJ, Mehta, S, et al. Protocol for a multicentre randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss: the STARFISH trial. PLos One 2024;19:e0290480CrossRefGoogle ScholarPubMed